Suita, Japan

Yoshitoshi Kaneda

This inventor holds 1 USPTO granted patent. Top assignees: Hiroshima University, Osaka University. Active years: 2012.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshitoshi Kaneda

Introduction

Yoshitoshi Kaneda is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biomaterials, particularly in the area of mesenchymal cell proliferation. His work has implications for regenerative medicine and tissue engineering.

Latest Patents

Kaneda holds a patent for a "Mesenchymal cell proliferation promoter and skeletal system biomaterial." This invention demonstrates that a SVVYGLR peptide (SEQ ID NO: 1) can promote the proliferation of mesenchymal cells, such as marrow-derived mesenchymal stem cells and dental pulp cells. The patent describes a carbonate apatite-collagen sponge containing the SVVYGLR peptide, which is useful as a biomaterial for regenerating bone marrow or dental pulp. This innovation provides a skeletal system biomaterial capable of promoting mesenchymal cell proliferation, serving as artificial bone marrow or dental pulp for repairing defects in bone marrow or dental pulp tissues.

Career Highlights

Throughout his career, Kaneda has been associated with prestigious institutions such as Osaka University and Hiroshima University. His research has focused on advancing the understanding and application of biomaterials in medical science.

Collaborations

Kaneda has collaborated with notable colleagues, including Hiroshi Egusa and Masayuki Okazaki. Their joint efforts have contributed to the advancement of knowledge in the field of regenerative medicine.

Conclusion

Yoshitoshi Kaneda's innovative work in mesenchymal cell proliferation and biomaterials highlights his significant contributions to medical science. His patent and collaborations reflect a commitment to advancing regenerative medicine and improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…